Ihre Auswahl

Es befinden sich keine Produkte im Warenkorb.

Transparency declaration

Dr. rer. nat. Anna Laven MSc MA is responsible for all content on www.pharmabrain.org. Dr. Laven assures that she does not pursue any advertising, commercial and/or ideological intentions beyond membership fees with the training measures on www.pharmabrain.org. Neither Dr. Laven nor Pharmabrain GmbH receives any other benefits for the content of the e-trainings on www.pharmabrain.org other than the membership fees of the participants. In order to maintain transparency beyond the content on www.pharmabrain.org, Dr. Anna Laven lists here her business relationships since she began working as a pharmaceutical-medical trainer. This list corresponds to the Specifications of the Federal Chamber of Pharmacists.

Dependent or voluntary employment

  • Managing Director of Pharmabrain GmbH, Berlin
  • Research assistant at the University of Münster Clinical Pharmacy / Individualized Pharmacotherapy
  • Lecturer in communication / patient behavior and cooperation partner in the AMTS study programg Rheinische Friedrich-Wilhelms-Universität, Bonn in cooperation with the Universities of Heidelberg and Tübingen
  • Employed pharmacist in Axel's pharmacy, Berlin
  • Founding member and former chairwoman of the board and editor of the Anna Laven Prize for interprofessional collaboration of the IP-Health Society for Interprofessional Healthcare, Munich

Fees

  • Pharmacy chambers/associations: Berlin Chamber of Pharmacists, Brandenburg Chamber of Pharmacists, Hamburg Chamber of Pharmacists, North Rhine Chamber of Pharmacists, North Rhine Pharmacists' Association, Saxony-Anhalt Chamber of Pharmacists, International Pharmaceutical Federation (FIP)
  • Trade unions: Adexa
  • Cooperations: A-plus, apogen, MVDA, Linda, ELAK, Pharma Privat
  • Pharmaceutical wholesale: Gehe, Phoenix, Pharma Privat, Noweda, Sanacorp
  • Pharmaceutical industry: Actelion, Aliud, Bayer, Belsana, Dermapharm, GSK, Hexal, Hübner, Klinge, Lundbeck, Manuka Health, Metafackler, Medice, Merck, Otsuka, Pierre Fabre, Schwabe, Shire, Spitzner, Stada, Niddapharm, TAD-Pharma
  • Publishers: Avoxa, Apo-Verlag AG, Govi-Verlag, DAV, Medical Tribune, Umschau-Verlag
  • More: Agfam, Apotheker- und Ärztebank, Clinical Research Center Salzburg, Omniamed, Rheinische Friedrich-Wilhelms-Universität Bonn, Treuhand

Financial support for scientific activities and patent applications

  • None

Other financial or non-cash benefits

  • None

Consulting activities

  • Business coaching for individuals and team coaching for pharmacy teams

Expert activity

  • None

Shareholdings

  • Sole shareholder of Pharmabrain GmbH

Other interests

  • Memberships (current only): Aktionsbündnis Patientensicherheit; Apotheker helfen e.V.; Apothekerkammer Berlin; Apothekerverband Nordrhein; Deutsche Diabetes Gesellschaft; Deutsche Gesellschaft für Psychiatrie und Psychotherapie, Psychosomatik und Nervenheilkunde; Deutsches Netzwerk für Evidenzbasierte Medizin; Deutsche Pharmazeutische Gesellschaft; ECNP; European Society for Cardiology; IP Health Society for Interprofessionalism in Healthcare e.V.; International Pharmaceutical Federation; Pharmaceutical Care Network Europe.

Publications / Posters / Congress contributions

2025

  • Laven A. Speak up! AMTS communication tools for the pharmacy. 1st ed. Eschborn: AVOXA - Media Group of German Pharmacists; 2025. 188 p. ISBN: 978-3-7741-1839-3.

2024

  • Mahler C, Stephan C, Laven A. Drug safety in the pharmacy: analysis of risk communication [Article in German]. Pharmakon. 2024 Sep;12(5):352-9. doi:10.1691/pn.20240038.
  • Wurmbach V, Stephan C, Hildebrandt J, Dartsch D, Laven A, Olejniczak K, Schoeppe C, Mahler C, Seidling H, Jaehde U. Continuing education, interprofessional master's program "Drug Therapy Safety": How do the participants evaluate the modules? [Abstract]. In: Proceedings of the 6th German Congress for Patient Safety in Drug Therapy; 2024 Oct 24-25; Berlin, Germany. Prescribing in practice. 2024 Oct;51(3):p. 51.

2021

  • Laven A, Bienentreu S, Nick B, Correll C. Motivational interviewing and schizophrenia: development of a training method to improve psychiatric counseling. ECNP Congress 2021, Poster.
  • Laven A, Bienentreu S, Nick B, Correll C. Motivational interviewing and schizophrenia: development of a training method to improve psychiatric counseling. DGPPN Congress 2021, oral presentation.

2020

  • Farahani I, Laeer S, Farahani S, Schwender H, Laven A. Blended learning: Improving the diabetes mellitus counseling skills of German pharmacy students. Curr PharmTeach Learn 2020, 963-974
  • Burckhardt BB, Ciplea AM, Laven AAblonczy L, Klingmann I, Laeer S, Kleine K, Dalinghaus M, Đukić M, Breur JMPJ, van der Meulen M, Swoboda V, Schwender H, Lagler FB. Simulation Training to Improve Informed Consent and Pharmacokinetic/Pharmacodynamic Sampling in Pediatric Trials. Frontiers in Pharmacology. 2020. 11:2137
  • Laven A, Thevisssen J, Böhmer A, Al Ghaddioui R, Olejniczak K, Dartsch D, Haenisch B, Mahler C, Paeschke N, Seidling H, Weltermann B, Woltersdorf R, Jaehde U. Do we need an interprofessional program for the safety of medication therapy? PCNE 2020 Egmont an Zee, the Netherlands; Poster

2019

  • Sousa Pinto G, Duggan C, Jacinto I, Oyeneyin Y, El Bizri L, Billberg K, Criddle D, Gharat M, Hogue M, Zhou Y, Bader L, Laven A. Beating non-communicable diseases in primary health care: the contribution of pharmacy. Research in Social and Administrative Pharmacy. 2019. 16(7):974-977

2018

  • Laven AArnet I. How pharmacists can encourage patient adherence to medicines. The Pharmaceutical Journal 2018;301(7916): Online. doi: 10.1211/PJ.2018.20205153
  • Laven ADeters M, Rose O, Smaranda A, Schwender H, Waltering I, et al. PharmAdhere: training German community pharmacists with Objective Structured Clinical Examinations. IJCP 2018. DOI 10.1007/s11096-018-0710-0.
  • Laven A, Schmitz K, Franzen WH. Reporting adverse drug reactions: Contribution, knowledge and perception of German pharmacy professionals. Int J Clin Pharm 2018. DOI 10.1007/s11096-018-0671-3.
  • Deters MA, Laven ACastejon A, Doucette WR, Ev LS, Krass I, et al. Effective Interventions for Diabetes Patients by Community Pharmacists: A Meta-analysis of Pharmaceutical Care Components. Ann Pharmacother. 2018 Feb;52(2):198-211
  • Laven A. A meta-analysis of pharmaceutical care components for diabetes patients provided by community pharmacists, PCNE Symposium 2018, Fuengirola, Spain; Oral presentation.
  • Laven A. PharmAdhere: Pharmacists train patient-centered counseling. 13th Conference of the Aktionsbündnis Patientensicherheit, Berlin, Germany, Oral presentation (German)
  • Laven A, Schmitz K, Franzen WH. Reporting of adverse drug reactions: Knowledge, attitude and contribution of pharmaceutical staff in Germany. 13th Conference of the Aktionsbündnis Patientensicherheit, Berlin, Germany, Poster (German)
  • Laven ADeters MA, Rose O, Schwender H, Smaranda A, Waltering I, Laeer S. PHARMADHERE Study: Training pharmacists for patient-centered care in compliance with adherence taxonomy, PCNE Symposium 2018, Fuengirola, Spain; Poster
  • Laven A, Deters MA, Rose O, Schwender H, Smaranda A, Waltering I, Laeer S.: Pharmadhere: training pharmacists for patient-centered care in compliance with adherence taxonomy. FIP World Congress 2018 Glasgow, United Kingdom; Poster
  • Laven A, Schmitz K, Franzen WH. Reporting ADRs: contribution, knowledge and perception of German pharmacy professionals. FIP World Congress 2018 Glasgow, United Kingdom; Poster

2017

  • Laven ADe Rango F, Rydant S, Costa F, Antoniou S. Pharmaceutical counseling on anticoagulation - Identifying needs of German community pharmacies, 10th PCNE Working Conference 2017, Bled, Slovenia; Poster.

2016

  • Burckhardt BB, Ciplea AM, Laven AKlingmann I, Läer S, Lagler FB. A novel simulation-based approach to train study teams for clinical trials in neonates, infants and children with heart failure, 50th Annual Meeting of the Association for European Paediatric and Congenital Cardiology, 2016, Rome; Poster.

2014

  • Laven A, Schaefer J, Laeer S (2014). PHARMAGRIPS: Structured PHARMAceutical counseling in the self-medication of GRIPpal infections. A randomized controlled trial (RCT). Med Monatsschr Pharm 2014; 37:209-220.
  • Laven ASchaefer J, Laeer S. PHARMAGRIPS: Structured pharmaceutical counseling in the self-medication of the common cold. A randomized controlled study (RCT). FIP Annual Meeting, Bangkok. 2014; Poster.
  • Laven A. Meine Apotheke. 1st edition GOVI Verlag Eschborn 2014; ISBN: 9783774112421.
  • Laven A. Help, a customer! 3rd expanded edition GOVI Verlag Eschborn 2014; ISBN: 9783774110908.

2013

  • Laven A. Why do I get something else? The PTA in the pharmacy 2013; 10:26.
  • Laven A. How can I get addicted to it? The PTA in the pharmacy 2013; 09:26.
  • Laven A. Can I also give this to my child? The PTA in the pharmacy 2013; 08:26.
  • Laven A. It works for me, but not for him. The PTA in the pharmacy 2013; 07:26.
  • Laven A. What's it to you? The PTA in the pharmacy 2013; 06:26.
  • Laven A. What are you taking? The PTA in the pharmacy 2013; 05:26.
  • Laven A. Isn't it all just placebo? The PTA in the pharmacy 2013; 04:26.
  • Laven ALaeer S: Pharmacists' need for evidence-based guidelines for self-medication. MMP 2013; 3:102-10
  • Laven A. The know-it-all. The PTA in the pharmacy 2013; 03:26.
  • Laven A. The most effective remedy? The PTA in the pharmacy 2013; 02:26.
  • Laven A. The best remedy? The PTA in the pharmacy 2013; 01:26.

2012

  • Laven A. Colleague leaves! What to do? The PTA in the pharmacy 2012; 12:24.
  • Laven A. Colleague tattles! What to do? The PTA in the pharmacy 2012; 11:26.
  • Laven A. Colleague is chatting! What to do? The PTA in the pharmacy 2012; 10:26.
  • Laven A. Colleague becomes boss! What to do? The PTA in the pharmacy 2012; 09:26.
  • Laven A. Colleague is lying! What to do? The PTA in the pharmacy 2012; 08:26.
  • Laven A. Colleague doesn't know the Internet! What to do? The PTA in the pharmacy 2012; 07:26.
  • Laven A. Colleague is crazy! What to do? The PTA in the pharmacy 2012; 06:26.
  • Laven A. My colleague stinks! What to do? The PTA in the pharmacy 2012; 05:24.
  • Laven A. Super colleague! What to do? The PTA in the pharmacy 2012; 04:26.
  • Laven A. Colleague is silent! What to do? The PTA in the pharmacy 2012, 03:26.
  • Laven A. New colleague! What to do? The PTA in the pharmacy 2012, 02:26.

2011

  • Laven A. Tips for talking to customers who know everything from the Internet. The PTA in the pharmacy 2011, 12:28.
  • Laven A. Right of way for vitamins and minerals. Pharmazeutische Zeitung, PTA-Forum 2011; 12:62-63.
  • Laven A. Tips for dealing with sexually intrusive customers. The PTA in the pharmacy 2011; 11:28.
  • Laven A. Nutrition for men. Pharmazeutische Zeitung, PTA-Forum 2011; 11:60-61.
  • Laven A. Tips for dealing with mystery shoppers. The PTA in the pharmacy 2011; 10:28.
  • Laven A. Support during the menopause. Pharmazeutische Zeitung, PTA-Forum 2011; 10:38-39.
  • Laven A. Tips for talking to customers who are not at all embarrassed. The PTA in the pharmacy 2011; 09:28.
  • Laven A. Strengthening the heart. Pharmazeutische Zeitung, PTA-Forum 2011; 09:32-33.
  • Laven A. Tips for talking to terminally ill customers. The PTA in the pharmacy 2011; 08:28.
  • Laven A. Seeing sharply for longer. Pharmazeutische Zeitung, PTA-Forum 2011; 08:48-49.
  • Laven A. Tips for talking about money. The PTA in the pharmacy 2011; 07:28.
  • Laven A. Proper care for children and adolescents. Pharmazeutische Zeitung, PTA-Forum 2011; 07:39.
  • Laven A. When the immune system has to work hard. Pharmazeutische Zeitung, PTA-Forum 2011; 06:52-53.
  • Laven A. Well done, customer! ADEXA, Spectrum 2011; 03:24.
  • Laven A. Tips for talking to completely insecure customers. The PTA in the pharmacy 2011; 06:24.
  • Laven A. Conversation tips for dealing with medically trained customers. The PTA in the pharmacy 2011; 05:28.
  • Laven A. Making exercise fun again. Pharmazeutische Zeitung, PTA-Forum 2011; 5:38-39.
  • Laven A. Tips for talking to grieving customers in busy times. The PTA in the pharmacy 2011; 04:28.
  • Laven A. Micronutrients for stress. Pharmazeutische Zeitung, PTA-Forum 2011; 4:54-55.
  • Laven A. Supplement food or promote recovery. Pharmazeutische Zeitung, PTA-Forum 2011; 03:56-58.
  • Laven A. Tips for talking to customers who are annoyed about discount agreements. The PTA in the pharmacy 2011; 03:28.
  • Laven A. Tips for talking to customers who know everything better. The PTA in the pharmacy 2011; 02:28.

2009

  • Carl B., Laven A. Raloxifene instead of hormones. Pharmazeutische Zeitung, PTA-Forum 2009; 12:14-16.
  • Carl B., Laven A. Teriparatide and calcitonin. Pharmazeutische Zeitung, PTA-Forum 2009; 11:38-40.
  • Carl B., Laven A. Strontium and fluoride. Pharmazeutische Zeitung, PTA-Forum 2009; 10:42-43.
  • Carl B., Laven A. Bisphosphonates in therapy. Pharmazeutische Zeitung, PTA-Forum 2009; 9:24-26.
  • Carl B., Laven A. Strong bones-strong life. Pharmazeutische Zeitung, PTA-Forum 2009; 8:16-17.
  • Laven A. Counseling competence in the pharmacy. Pharmacy in our time 2009; 5:448-453

2008

  • Carl B., Laven A. Some diabetics lose weight with incretin analogs. Pharmazeutische Zeitung, PTA-Forum 2008; 11:32-33.
  • Carl B., Laven A. Glitazones reduce insulin resistance. Pharmazeutische Zeitung, PTA-Forum 2008; 10:12-13.
  • Laven A., Kern M. Alcoholic drops for children. PTAtoday 2008, 21:42-43.
  • Carl B., Laven A. Mobilize the insulin reserves. Pharmazeutische Zeitung, PTA-Forum 2008; 9:28-29.
  • Carl B., Laven A. Blood glucose management with sulfonylureas. Pharmazeutische Zeitung, PTA-Forum 2008; 6:30-32.
  • Carl B., Laven A. The start into drug therapy. Pharmazeutische Zeitung, PTA-Forum 2008; 5:30-31.
  • Carl B., Laven A. Blood values determine the therapy. Pharmazeutische Zeitung, PTA-Forum 2008; 4:30-31.
  • Carl B., Laven A. The correct handling of insulin needs to be learned. Pharmazeutische Zeitung, PTA-Forum 2008; 3:28-29.
  • Laven A. Breaking out of nicotine addiction. Pharmazeutische Zeitung 2008; 9:18-25.
  • Carl B., Laven A. The pharmacy team can make a difference. Pharmazeutische Zeitung, PTA-Forum 2008; 2:25-28.
  • Laven A. Help, a customer! 2nd expanded edition GOVI Verlag 2008

2007

  • Carl B., Laven A. Medicines for special cases. Pharmazeutische Zeitung, PTA-Forum 2007; 12:30-31.
  • Carl B., Laven A. Anticholinergics for long breath. Pharmazeutische Zeitung, PTA-Forum 2007; 11:42-43.
  • Carl B., Laven A. Determine the dose individually. Pharmazeutische Zeitung, PTA-Forum 2007; 10:42-43.
  • Carl B., Laven A. Strengthen self-management. Pharmazeutische Zeitung, PTA-Forum 2007; 9:36-37.
  • Laven A. Valuable data from the pharmacy. Pharmazeutische Zeitung 2007; 38:20-30.
  • Carl B., Laven A. Rehearsing for an emergency. Pharmazeutische Zeitung, PTA-Forum 2007; 8:26-27.
  • Carl B., Laven A. Therapy of menstruation-associated migraine. German Pharmacist Journal 2007; 31:56-57.
  • Carl B., Laven A. Glucocorticoids correctly inhaled. Pharmazeutische Zeitung, PTA-Forum 2007; 7:18-20.
  • Carl B., Laven A. Correct inhalation needs to be learned. Pharmazeutische Zeitung, PTA-Forum 2007; 6:32-34.

2006

  • Laven A. Overcoming prejudices and fears. Pharmazeutische Zeitung, PTA-Forum 2006; 12:21-22.
  • Carl B., Laven A. Permanently pain-free. Pharmazeutische Zeitung, PTA-Forum 2006; 11:20-21.
  • Carl B., Laven A. Available over the counter depending on dose. Pharmazeutische Zeitung, PTA-Forum 2006; 10:40-41.
  • Laven A. Help, a customer! GOVI publishing house 2006;
  • Carl B., Laven A. Observe the correct dose. Pharmazeutische Zeitung, PTA-Forum 2006; 9:20-22.
  • Carl B., Laven A. One active ingredient for many. Pharmazeutische Zeitung, PTA-Forum 2006; 8:38-39.
  • Katzfey U., Laven A. Take the customers as they are. Pharmazeutische Zeitung, PTA-Forum 2006; 7:32.
  • Carl B., Laven A. Well known and well researched. Pharmazeutische Zeitung, PTA-Forum 2006; 7:24-25.
  • Carl B., Laven A. Pain as a warning signal. Pharmazeutische Zeitung, PTA-Forum 2006; 6:12-13.
  • Obermayr R., Laven A. Ask whether acute or chronic. Pharmazeutische Zeitung, PTA-Forum 2006; 5:33-34.
  • Philipp M., Laven A. Preserving dignity and creating trust. Pharmazeutische Zeitung, PTA-Forum 2006; 4:46-47.
  • Carl B., Laven A. Drinking is the top priority. Pharmazeutische Zeitung, PTA-Forum 2006; 3:26-27.
  • Carl B., Laven A. Binding or glancing gastric acid. Pharmazeutische Zeitung, PTA-Forum 2006; 2:34-35.

2005

  • Carl B., Laven A. Preventing ingestion errors. Pharmazeutische Zeitung, PTA-Forum 2005; 12:36-37.
  • Carl B., Laven A. Sensible support for therapy. Pharmazeutische Zeitung, PTA-Forum 2005; 11:50-52.
  • Carl B., Laven A. Improving patient compliance. Pharmazeutische Zeitung, PTA-Forum 2005; 9:14.
  • Carl B., Laven A. Patients want good tolerability. Pharmazeutische Zeitung, PTA-Forum 2005; 7:19.
  • Carl B., Laven A. Patients need a lot of patience. Pharmazeutische Zeitung, PTA-Forum 2005; 6:30-31.
  • Carl B., Laven A. Overview of drug therapy. Pharmazeutische Zeitung, PTA-Forum 2005; 5:10-11.
  • Laven A. Preventing stress on vacation. Pharmazeutische Zeitung 2005; 16:24-26.
  • Laven A. Anti-aging medicine: Younger through drugs. PTA-today-Congress 2005; 4:105-108.
  • Carl B., Laven A. Overview of affective disorders. Pharmazeutische Zeitung, PTA-Forum 2005; 4:28-29.
  • Carl B., Laven A. Correct advice on calcium antagonists. Pharmazeutische Zeitung, PTA-Forum 2005; 3:14.
  • Carl B., Laven A. Correct advice on ACE inhibitors. Pharmazeutische Zeitung, PTA-Forum 2005; 2:20.
  • Carl B., Laven A. Correct advice on beta-blockers. Pharmazeutische Zeitung, PTA-Forum 2005; 1:22.

2004

  • Carl B., Laven A. Correct advice on diuretics. Pharmazeutische Zeitung, PTA-Forum 2004; 12:24.
  • Carl B., Laven A. Correct advice on antihypertensives. Pharmazeutische Zeitung, PTA-Forum 2004; 11:18.
  • Carl B., Laven A. Correct advice on antihypertensives. Pharmazeutische Zeitung, PTA-Forum 2004; 10:12.
  • Carl B., Laven A. Correct advice on antibiotic side effects. Pharmazeutische Zeitung, PTA-Forum 2004; 7:20.
  • Carl B., Laven A. Correct advice on ciprofloxacin. Pharmazeutische Zeitung, PTA-Forum 2004; 6:10.
  • Carl B., Laven A. Correct advice on tetracyclines. Pharmazeutische Zeitung, PTA-Forum 2004; 5:18.
  • Carl B., Laven A. Correct advice on macrolides. Pharmazeutische Zeitung, PTA-Forum 2004; 4:24.
  • Carl B., Laven A. Correct advice on clindamycin. Pharmazeutische Zeitung, PTA-Forum 2004; 3:12.
  • Carl B., Laven A. Correct advice on amoxicillin. Pharmazeutische Zeitung, PTA-Forum 2004; 2:24.
  • Carl B., Laven A. Correct advice on antibiotics. Pharmazeutische Zeitung, PTA-Forum 2004; 1:25.

2003 and before

  • Laven A. Micronutrient requirements during pregnancy and lactation. Pharma-Rundschau 2003; 12:40-44.
  • Laven A. Micronutrient requirements during pregnancy and lactation. Pharma-Rundschau 2003; 3:30.
  • Laven A. Nutrition in old age. PZ-Prisma 2003; 2:86-90.
  • Laven A. Diaper dermatitis-Little effort for a lot of well-being. Pharma-Rundschau 2002; 5:60-62.
  • Laven A. Adult fungal infections and intertrigo. European Hospital 2002; 4:11.
  • Carl B., Laven A. The communicative path to Pharmaceutical Care and an example in five steps. PZ-Prisma 2002; 1:33-40.
  • Laven A. 1-2-3: Diarrhea-free. Pharma Rundschau 2001; 7/8:32-33.
  • Laven A. How is consulting quality created? ANZAG Magazine 2001; 12/1:30-31.
  • Laven A. Those who are positively different will win. ANZAG Magazine 2000; 6/7:30-31.
  • Laven A. From sunscreen to sun treasure. PTA today 2000; 6:33-34.
  • Laven A. The treatment of acute diarrheal diseases. Pharma Rundschau 2000; 6:74-78.
  • Friderich G., Laven A. Quality standards in the counseling interview. PZ Prisma 1999; 1:48-54.
  • Laven A. Treatment of acute diarrheal diseases. Pharma Rundschau 1999; 6:68-71.
  • Laven A. The treatment of acute diarrheal diseases. Pharma Rundschau 1999; 3/99.
  • Laven A. The package insert. Pharmazeutische Zeitung, PTA-Forum 1999; 5:9